Gene information provision device, method, and program

Abstract

To provide a genetic information providing device, a method, and a program that facilitate linkage of genetic information.SOLUTION: A genetic information providing device according to an embodiment of the present invention includes: a request acquisition unit that receives a request from a partner company terminal to provide customer genetic information; a consent acquisition unit that receives consent from the customer to provide the genetic information from a customer terminal; and a genetic information providing unit that provides, upon receiving the consent, genetic information of the customer to the partner company terminal.SELECTED DRAWING: Figure 4

Description

Technical Field

[0001] The present invention relates to a gene information providing apparatus, method, and program.

Background Art

[0002] Conventionally, a gene test is known that can obtain information such as an individual's disease onset risk and constitution by reading and analyzing genetic information contained in genes (Patent Document 1). Specifically, a customer purchases a gene test kit from a company that provides a gene test service, collects his or her own sample, and returns it. Thereafter, the customer can view the results of the gene test on a website.

[0003] It is expected that the results of such gene tests will be utilized by partner companies such as pharmacies.

Prior Art Documents

Patent Documents

[0004]

Patent Document 1

Summary of the Invention

Problems to be Solved by the Invention

[0005] 9]However, the results of gene tests are confidential information, and a certain level of security is required for the management of the data of the results of gene tests. Therefore, it has not been easy for partner companies to construct or operate a system for receiving the data of the results of gene tests from a company that provides a gene test service. Also, on the customer side that provides gene information, it has been difficult to grasp to which company, when, and what information has been shared.

[0006] Therefore, an object of the present invention is to realize the cooperation of gene information in a safe, easy, and traceable state.

Means for Solving the Problems

[0007] A genetic information providing device according to one embodiment of the present invention comprises: a request acquisition unit that receives a request from a partner company terminal to provide the customer's genetic information; a consent acquisition unit that receives the customer's consent to provide the genetic information from the customer terminal; and a genetic information providing unit that, upon receiving the consent, provides the customer's genetic information to the partner company terminal.

[0008] According to the present invention, the linking of genetic information can be easily realized. [Brief explanation of the drawing]

[0009] [Figure 1] This diagram shows the overall configuration of one embodiment of the present invention. [Figure 2] This is a diagram illustrating the outline of the present invention (in the case where the collaborating company has a physical store). [Figure 3] This is a diagram illustrating the outline of the present invention (in the case where the collaborating company is an online store). [Figure 4] This is a functional block diagram of a gene information provision device according to one embodiment of the present invention. [Figure 5] This is an example of an authentication information database related to one embodiment of the present invention. [Figure 6] This is an example of a database of partner companies related to one embodiment of the present invention. [Figure 7] This is an example of a customer database relating to one embodiment of the present invention. [Figure 8] This is a sequence diagram of the gene information linkage processing according to one embodiment of the present invention (when the collaborating company is a physical store). [Figure 9] This is a sequence diagram of the gene information linkage processing according to one embodiment of the present invention (when the cooperating company is an online store). [Figure 10] This is an example of a screen transition diagram (genetic information sharing) displayed on a partner company terminal according to one embodiment of the present invention. [Figure 11] This is an example of a screen transition diagram (linking of genetic information) displayed on a customer terminal according to one embodiment of the present invention. [Figure 12] This is an example of a screen transition diagram (linking history) displayed on a customer terminal according to one embodiment of the present invention. [Figure 13] This is a hardware configuration diagram of a gene information providing device according to one embodiment of the present invention. [Modes for carrying out the invention]

[0010] Embodiments of the present invention will be described below with reference to the drawings.

[0011] <Explanation of Terms> In this specification, "genetic information" refers to information obtained by analyzing DNA (DeoxyriboNucleic Acid) extracted from a sample such as a customer's saliva (i.e., the results of a genetic test). Specifically, "genetic information" refers to the base sequence information represented by "ATGC" obtained as a result of genetic analysis, and various accompanying information such as risk values ​​for "health risks" and "constitution" determined from this information, disease names, constitution names, their summaries, prevention methods, and research paper information. For example, genetic information includes, but is not limited to, health risks (disease risk, disease onset risk) and constitution. Genetic testing analyzes various health risks and constitutions (i.e., genetic information consists of multiple items). In this specification, "partner company" refers to a company that provides services tailored to a customer's genetic information. For example, partner companies include, but are not limited to, pharmacies, gyms (training gyms, sports gyms, etc.), clinics / cosmetic clinics, health insurance associations, and mail-order supplement companies. For example, a pharmacy may check genetic information related to individual differences in drug responsiveness, a gym may check genetic information related to diet and muscle, a clinic / cosmetic clinic may check genetic risk of disease and genetic information related to beauty, a health insurance association may check relevant genetic information for health checkups, and a mail-order supplement company may check genetic risk of disease and nutrients that are genetically deficient.

[0012] <Overall Structure> FIG. 1 is a diagram showing the overall configuration according to an embodiment of the present invention. The gene information providing system 1 includes a gene information providing device 10, a partnering company terminal 20, and a customer terminal 30. The gene information providing device 10, the partnering company terminal 20, and the customer terminal 30 are communicably connected to each other via an arbitrary network. Each will be described below.

[0013] <<Gene information providing device>> The gene information providing device 10 is a device for collaborating the customer's gene information with a partnering company (for example, displaying the customer's gene information on the partnering company terminal 20 for only a certain period). Note that the gene information providing device 10 is composed of one or more computers.

[0014] <<Partnering company terminal>> The partnering company terminal 20 is a terminal for collaborating the customer's gene information (for example, displaying the customer's gene information). For example, the partnering company terminal 20 is a personal computer, a tablet, a smartphone, etc. installed in the partnering company.

[0015] <<Customer terminal>> The customer terminal 30 is a terminal for the customer to input consent for the collaboration of gene information (that is, the customer's gene information is provided to the partnering company terminal 20). For example, the customer terminal 30 is a personal computer, a tablet, a smartphone, etc. owned by the customer.

[0016] <Summary> The summary of the present invention will be described with reference to FIGS. 2 and 3.

[0017] FIG. 2 is a diagram for explaining the summary of the present invention (when the partnering company has a physical store).

[0018] In step 11 (S11), customer 31 purchases a genetic testing kit and receives the results of the genetic test. For example, customer 31 purchases a genetic testing kit from company 11 that provides genetic testing services, collects their own sample, and sends it back to company 11. After that, customer 31 can view the results of the genetic test on a website provided by company 11.

[0019] In step 12 (S12), customer 31 visits a physical store of partner company 21 (for example, a pharmacy). Customer 31 may also contact partner company 21's physical store by phone in advance to make a reservation.

[0020] In step 13 (S13), a person from the collaborating company 21 (for example, a pharmacist at a pharmacy) uses the collaborating company terminal 20 to log in to the website provided by the genetic testing service provider 11 (that is, to send the collaborating company 21's identification information (for example, company ID and password) to the genetic information providing device 10) and sends a request to the genetic information providing device 10 to display the customer's genetic information.

[0021] In step 14 (S14), a one-time password is displayed on the linked company terminal 20.

[0022] In step 15 (S15), a person from the collaborating company 21 (for example, a pharmacist at a pharmacy) informs customer 31 of the one-time password displayed in S14 verbally or by other means (this may also be done by phone, social media, email, etc.).

[0023] In step 16 (S16), customer 31 uses customer terminal 30 to log in to the website provided by genetic testing service provider 11 (i.e., transmit customer 31's identification information (e.g., customer ID, password) to genetic information provider device 10), and transmits the one-time password provided in S15 and consent to the linking of genetic information (i.e., customer 31's genetic information being displayed on the linking company terminal 20) to the genetic information provider device 10.

[0024] In step 17 (S17), the gene information providing device 10 displays the gene information linked to the customer 31's identification information (e.g., customer ID) from S16 on the partner company terminal 20 (for the partner company 21's identification information (e.g., company ID) from S13) for a limited period of time. Note that the gene information displayed is limited to the range defined for each partner company (for example, only gene information for specific items (e.g., "diet", "cerebral infarction", "SNP0001") is displayed for ○△□ Corporation).

[0025] In step 18 (S18), the collaborating company 21 provides the customer 31 with a service corresponding to the genetic information in S17.

[0026] In step 19 (S19), customer 31 pays the service fee for S18. However, this does not apply if the service utilizing genetic information is included in the existing service fee.

[0027] Figure 3 is a diagram illustrating the outline of the present invention (in the case where the collaborating company is an online store).

[0028] In step 21 (S21), customer 31 purchases a genetic testing kit and receives the results of the genetic test. For example, customer 31 purchases a genetic testing kit from company 11 that provides genetic testing services, collects their own sample, and sends it back to company 11. After that, customer 31 can view the results of the genetic test on a website provided by company 11.

[0029] In step 22 (S22), customer 31 requests a service from partner company 21 that corresponds to their genetic information (for example, they might try to purchase supplements from an online store on the internet provided by partner company terminal 20).

[0030] In step 23 (S23), the collaborating company terminal 20 calls the API (Application Programming Interface) of the gene information providing device 10 to request that the customer 31's gene information be displayed and shared. The collaborating company 21 will use the collaborating company terminal 20 to log in to the website provided by the gene testing service provider 11 (i.e., send the collaborating company 21's identification information (e.g., company ID, password) to the gene information providing device 10).

[0031] In step 24 (S24), the genetic information provision device 10 sends a confirmation to the customer terminal 30 asking whether the customer consents to the sharing of genetic information (i.e., the customer's genetic information being displayed and shared on the collaborating company terminal 20).

[0032] In step 25 (S25), customer 31 uses customer terminal 30 to send consent to the genetic information provider device 10 for the sharing of genetic information (i.e., for customer 31's genetic information to be displayed and shared on the collaborating company terminal 20).

[0033] In step 26 (S26), the gene information providing device 10 may display the customer's 31 gene information requested in S23 on the partner company terminal 20 via API for a limited period of time, or it may share it with the partner company terminal 20 if the customer's consent is obtained. Note that only gene information within a range determined for each partner company (for example, ○△□ Corporation will only display and share gene information on predetermined items (for example, "diet", "cerebral infarction", "SNP0001"))).

[0034] In step 27 (S27), the collaborating company 21 provides the customer 31 with a service corresponding to the genetic information in S26.

[0035] In step 28 (S28), customer 31 pays the service fee for S27. However, this does not apply if the service utilizing genetic information is included in the existing service fee.

[0036] <Function Block> Figure 4 is a functional block diagram of a gene information providing device 10 according to one embodiment of the present invention. The gene information providing device 10 can include a request acquisition unit 101, an authentication information issuance unit 102, a consent acquisition unit 103, a gene information providing unit 104, an authentication information DB (database) 105, a partner company DB (database) 106, and a customer DB (database) 107. Furthermore, the gene information providing device 10 can function as the request acquisition unit 101, the authentication information issuance unit 102, the consent acquisition unit 103, and the gene information providing unit 104 by executing a program. Each of these will be described below.

[0037] The request acquisition unit 101 receives a request from the partner company terminal 20 to provide (e.g., display or share) the customer's genetic information. The request acquisition unit 101 also receives the partner company's identification information (e.g., company ID) from the partner company terminal 20. Specifically, the request acquisition unit 101 accepts the login of the partner company terminal 20 to the website provided by the genetic testing service provider 11 (i.e., transmits the partner company's identification information (e.g., company ID, password) to the genetic information providing device 10).

[0038] The authentication information issuing unit 102 issues authentication information for one-time authentication, linked to the identification information of the partner company (e.g., company ID), in response to a request for the customer to provide (e.g., display) their genetic information. The authentication information issuing unit 102 also transmits this authentication information to the partner company terminal 20. For example, the authentication information for one-time authentication is a one-time password, but is not limited to this; any authentication information that is valid only once is acceptable. For example, the authentication information for one-time authentication may be a QR code (registered trademark), passcode, physical key, card, authentication application, etc. When the customer consents to providing their genetic information, the authentication information for one-time authentication is immediately disabled.

[0039] The consent acquisition unit 103 displays a screen on the customer terminal 30 showing the name of the collaborating company, the collaboration items, the collaboration period, and precautions. When the customer gives their consent, the unit receives the customer's consent from the customer terminal 30 to provide (for example, display or share) genetic information.

[0040] If the partner company is a physical store, the consent acquisition unit 103 receives authentication information for one-time authentication and customer identification information (for example, customer ID) from the customer terminal 30.

[0041] When the consent acquisition unit 103 receives consent, the genetic information provision unit 104 provides (for example, displays or shares) the customer's genetic information to the linked company terminal 20.

[0042] If the partner company is a physical store, the genetic information provision unit 104 displays the genetic information linked to the customer's identification information (e.g., customer ID) received by the consent acquisition unit 103 on the partner company terminal 20 for a limited period of time (i.e., for the identification information of the partner company 21 (e.g., company ID) linked to the one-time authentication information received by the consent acquisition unit 103). If the partner company is an online store, the genetic information provision unit 104 may display the customer's genetic information on the partner company terminal 20 for a limited period of time via API, or may share it with the partner company terminal 20 if the customer 31 consents.

[0043] Furthermore, the genetic information provision unit 104 can provide genetic information within the scope defined for each collaborating company (specifically, genetic information for "items" registered in the collaborating company database 106) to the collaborating company terminal 20.

[0044] Furthermore, the genetic information provision unit 104 can display the customer's genetic information linkage history on the customer terminal 30.

[0045] The authentication information database 105 is a database that links authentication information (e.g., one-time passwords) issued by the authentication information issuing unit 102, the identification information of the partner company that manages the partner company terminal 20 to which the authentication information (e.g., one-time passwords) is sent, and the identification information of the customer that manages the customer terminal 30 to which the authentication information (e.g., one-time passwords) is sent.

[0046] The Partner Company Database 106 is a database that links the identification information of partner companies with the items of genetic information to be linked and their expiration dates.

[0047] Customer database 107 is a database that links customer identification information, customer contact information, and the results of their genetic testing.

[0048] <Data structure> Figure 5 shows an example of an authentication information database 105 according to one embodiment of the present invention. The authentication information database 105 includes authentication information (e.g., one-time password), identification information of partner companies (e.g., company ID), and identification information of customers (e.g., customer ID).

[0049] The "one-time password" stores the one-time password issued by the authentication information issuing unit 102 of the gene information providing device 10.

[0050] The "Company ID" field stores the ID of the partner company to which the one-time password is sent (specifically, the ID of the partner company operating the partner company terminal 20 and the ID of the operator belonging to that company).

[0051] The "Customer ID" field stores the customer ID of the customer managing customer terminal 30, which is the source of the one-time password.

[0052] Figure 6 shows an example of a partner company database 106 according to one embodiment of the present invention. The partner company database 106 includes identification information of partner companies (e.g., company ID and company name), items of linked genetic information, and expiration date.

[0053] The "Company ID" field stores the company IDs of partner companies that have been pre-registered for the purpose of linking genetic information.

[0054] The "Company Name" field stores the name of the collaborating company.

[0055] The "Items" section stores the items of the linked genetic information.

[0056] The "Expiration Date" field stores the expiration date for providing (e.g., displaying or sharing) the genetic information (e.g., the time the genetic information can be viewed on the partner company's terminal 20). Once the expiration date has passed, the genetic information will be hidden from the website.

[0057] Figure 7 shows an example of a customer database 107 according to one embodiment of the present invention. The customer database 107 includes customer identification information (e.g., customer ID), customer contact information (e.g., email address), and genetic test results.

[0058] The "Customer ID" field stores the customer ID of the customer who applied for the genetic test. Note that an email address may also be used as the customer ID.

[0059] The "email address" field stores the customer's email address.

[0060] The "Genetic Test Results" section stores the customer's genetic test results (i.e., genetic information for all items). Note that base sequence information (ATGC) and various supplementary information (such as risk values ​​calculated based on base sequence information (ATGC), disease information, prevention methods, and research paper information) may be managed across multiple tables.

[0061] <Processing method> Figure 8 is a sequence diagram of the gene information linkage processing according to one embodiment of the present invention (when the collaborating company is a physical store).

[0062] In step 100 (S100), the collaborating company terminal 20 registers the collaborating company's information (for example, the items of genetic information to be shared, the expiration date of the display of genetic information, etc.) with the genetic information providing device 10. Note that S100 only needs to be performed once and does not need to be performed each time genetic information is shared.

[0063] In step 101 (S101), the collaborating company terminal 20 sends a request to the gene information provider 10 asking it to display the customer's genetic information. For example, a person from the collaborating company uses the collaborating company terminal 20 to log in to the website provided by the gene information provider 10 (that is, they send the collaborating company's identification information (e.g., company ID, password) to the gene information provider 10) and sends a request to the gene information provider 10 asking it to display the customer's genetic information. Subsequently, the gene information provider 10 (request acquisition unit 101) receives the request from the collaborating company terminal 20 asking it to display the customer's genetic information.

[0064] In step 102 (S102), the gene information providing device 10 (authentication information issuing unit 102) issues authentication information for one-time authentication (e.g., a one-time password) in response to the request in S101, and transmits the authentication information (e.g., a one-time password) to the linked company terminal 20. At the time of S102, the one-time password and the company ID are linked.

[0065] In step 103 (S103), the customer terminal 30 transmits a one-time password to the gene information providing device 10. For example, a person from a collaborating company conveys the authentication information (e.g., a one-time password) displayed on the collaborating company terminal 20 in S102 to the customer. The customer enters the authentication information (e.g., a one-time password) and the customer's identification information (e.g., customer ID) into the customer terminal 30 and transmits it to the gene information providing device 10. Subsequently, the gene information providing device 10 (consent acquisition unit 103) receives the authentication information (e.g., a one-time password) and the customer's identification information (e.g., customer ID) from the customer terminal 30.

[0066] Specifically, the customer terminal 30 logs in to a website provided by the genetic testing service provider 11 (i.e., it sends the customer's identification information (e.g., customer ID, password) to the genetic information provider device 10). The customer is then given authentication information (e.g., a one-time password) by a representative of the partner company. The customer then enters the authentication information (e.g., a one-time password) into the customer terminal 30. After that, a screen showing the partner company name, collaboration items, collaboration deadline, and notes is displayed on the customer terminal 30, and if the customer agrees, the process proceeds to step 104.

[0067] In step 104 (S104), the gene information providing device 10 (gene information providing unit 104) displays the gene information linked to the customer identification information (e.g., customer ID) from S103 on the linked company terminal 20 for a limited period of time.

[0068] Figure 9 is a sequence diagram of the gene information linkage processing according to one embodiment of the present invention (when the collaborating company is an online store).

[0069] In step 201 (S201), the customer terminal 30 sends a request to the partner company terminal 20 requesting the provision of a service (for example, mail-order sales of supplements) that corresponds to the customer's genetic information. The customer terminal 30 sends the customer ID (for example, an email address may be used as the customer ID) to the partner company terminal 20.

[0070] In step 202 (S202), the collaborating company terminal 20 calls the API of the gene information provision device 10 and requests that it share the customer's gene information (authenticating the customer by sending customer identification information (e.g., customer ID such as an email address)).

[0071] In step 203 (S203), the genetic information providing device 10 sends a confirmation to the customer's customer terminal 30, which has the customer identification information (e.g., customer ID) from S202, asking whether the customer consents to the sharing of genetic information (i.e., the sharing of the customer's genetic information with the collaborating company terminal 20). Specifically, a screen showing the collaborating company name, sharing items, sharing deadline, and notes is displayed on the customer terminal 30.

[0072] In step 204 (S204), the gene information providing device 10 receives consent from the customer terminal 30 for the sharing of gene information (i.e., for the sharing of customer 31's gene information with the collaborating company terminal 20).

[0073] In step 205 (S205), the gene information providing device 10 may share the gene information linked to the customer identification information (e.g., customer ID) from S203 with the partner company terminal 20 via API, or, as described above, may display it on the partner company terminal 20 for a limited period of time.

[0074] <Screen> Figure 10 is an example of a screen transition diagram (genetic information sharing) displayed on the linked company terminal 20 according to one embodiment of the present invention.

[0075] In step 1001 (S1001), a screen is displayed for sending a request to the genetic information provider 10 to display the customer's genetic information. For example, a person from a partner company enters the customer information at the partner company (e.g., customer name or ID) and selects the new registration button.

[0076] In step 1002 (S1002), a screen is displayed prompting the user to present authentication information (e.g., a one-time password). This screen may also display the integration status (current integration status), integration date and time (date and time the integration started), integration deadline (deadline for integration), registrant (person from the integration company), registration date and time, updater (person from the integration company), and update date and time.

[0077] At step S1002, the connection status is not yet established. Subsequently, once the gene information providing device 10 receives authentication information (e.g., a one-time password) and customer identification information from the customer terminal 30, it becomes possible to proceed to the screen in step 1003.

[0078] In step 1003 (S1003), a screen is displayed to show the customer's genetic test results. For example, a representative from a partner company selects the test results button. Subsequently, genetic information for items of the customer's genetic information that can be shared with the partner company is displayed.

[0079] Figure 11 is an example of a screen transition diagram (linking of genetic information) displayed on a customer terminal 30 according to one embodiment of the present invention.

[0080] In step 2001 (S2001), a screen is displayed to initiate the linking of the customer's genetic information. For example, the customer selects the linking button.

[0081] In step 2002 (S2002), a screen is displayed for entering authentication information (e.g., a one-time password). For example, the customer enters the authentication information (e.g., a one-time password) provided by a representative of the partner company and sends it to the gene information providing device 10.

[0082] In step 2003 (S2003), the name of the collaborating company to which genetic information will be shared, the items of genetic information to be shared, and the expiration date of the sharing are displayed. After the customer confirms the name of the collaborating company to which genetic information will be shared, the items to be shared, the sharing expiration date, etc., and agrees to the sharing of genetic information and selects the agree button, the genetic information will be displayed on the collaborating company terminal 20.

[0083] Figure 12 is an example of a screen transition diagram (linking history) displayed on a customer terminal 30 according to one embodiment of the present invention.

[0084] In step 2101 (S2101), a list of partner companies with which the customer's genetic information has been linked in the past is displayed. For example, for each partner company, the linkage date and time (when the linkage started), partner company (company name), linkage expiration date (when the linkage ended), and linkage status (current linkage status) are displayed. When the customer selects any of the partner companies, the process proceeds to step 2102.

[0085] In step 2102 (S2102), details about the customer's genetic information linkage are displayed. For example, the one-time password, linkage status (current linkage status), linkage date and time (date and time the linkage started), linkage expiration date (expiration date of the linkage), name of the linking company, address of the linking company, inquiry email address, telephone number, and linkage items (items of genetic information that were linked) are displayed.

[0086] Furthermore, blockchain technology may be used to prevent tampering with the transaction history.

[0087] <Effects> In this invention, the results of genetic testing are provided to partner companies only after obtaining the individual's consent, thus preventing the leakage of customer genetic information data.

[0088] Furthermore, in one embodiment of the present invention, the results of a genetic test can be temporarily displayed on the partner company's terminal using a one-time password. Since the genetic information data itself is not transferred to the partner company and can only be viewed on a designated screen, security can be ensured. In addition, by using a one-time password, it is possible to avoid mistakes in the destination of the genetic information and for customers to confirm the items to be shared before sharing.

[0089] <Hardware Configuration> Figure 13 is a hardware configuration diagram of a gene information providing device 10 according to one embodiment of the present invention.

[0090] The gene information providing device 10 includes a CPU (Central Processing Unit) 1001, a ROM (Read Only Memory) 1002, and a RAM (Random Access Memory) 1003. The CPU 1001, ROM 1002, and RAM 1003 form a so-called computer. The gene information providing device 10 may also include an auxiliary storage device 1004, a display device 1005, an operating device 1006, an I / F (Interface) device 1007, and a drive device 1008. The various hardware components of the gene information providing device 10 are interconnected via bus B.

[0091] The CPU 1001 is a computing device that executes various programs installed on the auxiliary storage device 1004.

[0092] ROM1002 is non-volatile memory. ROM1002 functions as a main memory device that stores various programs, data, etc., necessary for the CPU1001 to execute the various programs installed on the auxiliary storage device 1004. Specifically, ROM1002 functions as a main memory device that stores boot programs such as BIOS (Basic Input / Output System) and EFI (Extensible Firmware Interface).

[0093] RAM1003 is a volatile memory such as DRAM (Dynamic Random Access Memory) or SRAM (Static Random Access Memory). RAM1003 functions as a main memory device that provides a working area that is expanded when various programs installed on the auxiliary storage device 1004 are executed by the CPU 1001.

[0094] The auxiliary storage device 1004 is an auxiliary storage device that stores various programs and information used when various programs are executed.

[0095] The display device 1005 is a display device that displays the internal state of the gene information providing device 10, etc.

[0096] The operating device 1006 is an input device in which the administrator of the gene information providing device 10 inputs various instructions to the gene information providing device 10.

[0097] The I / F device 1007 is a communication device that connects to a network and communicates with other devices.

[0098] The drive device 1008 is a device for setting the storage medium 1009. The storage medium 1009 here includes media that record information optically, electrically, or magnetically, such as CD-ROMs, flexible disks, and magneto-optical disks. The storage medium 1009 may also include semiconductor memory that records information electrically, such as ROMs and flash memory.

[0099] The various programs to be installed in the auxiliary storage device 1004 are installed, for example, when the distributed storage medium 1009 is set in the drive device 1008, and the various programs recorded on the storage medium 1009 are read by the drive device 1008. Alternatively, the various programs to be installed in the auxiliary storage device 1004 may be installed by downloading them from the network via the I / F device 1007.

[0100] It should be noted that the present invention is not limited to the configurations shown in the above embodiments, including combinations with other elements. These aspects can be modified without departing from the spirit of the present invention and can be appropriately determined according to their application. [Explanation of Symbols]

[0101] 1. Genetic Information Provision System 10 Genetic Information Provision Device 11 Genetic Testing Service Providers 20 Partner company terminals 21 Partner Companies 30 Customer terminals 31 Customer 101 Request acquisition part 102 Authentication Information Issuance Department 103 Consent Obtaining Department 104 Genetic Information Provision Department 105 Authentication Information Database 106 Partner Company Database 107 Customer Database 1001 CPU 1002 ROM 1003 RAM 1004 Auxiliary storage device 1005 Display device 1006 Operating device 1007 I / F device 1008 Drive unit 1009 Storage medium

Claims

1. A request acquisition unit that receives requests from partner company terminals to provide customer genetic information, In response to a request to provide the aforementioned customer's genetic information, the authentication information issuing unit transmits authentication information for one-time authentication to the aforementioned partner company's terminal, A consent acquisition unit that receives the customer's consent to provide the genetic information, the authentication information entered into the customer terminal by the customer who was informed of the authentication information received by the collaborating company terminal, and the customer's identification information from the customer terminal, Upon receiving the aforementioned consent, authentication information, and identification information, the Genetic Information Provision Unit displays the genetic information linked to the customer's identification information on the linked company's terminal for a limited period of time. A genetic information provision device equipped with these features.

2. The gene information providing device according to claim 1, wherein the gene information providing unit provides gene information within a range determined for each collaborating company to the collaborating company's terminal.

3. The gene information providing device according to claim 1 or 2, wherein the gene information providing unit displays the customer's gene information linkage history on the customer terminal.

4. A method performed by a gene information provider, The steps include receiving a request from a partner company's terminal to provide the customer's genetic information, In response to a request to provide the customer's genetic information, the step of transmitting authentication information for one-time authentication to the linked company's terminal, The steps include receiving the customer's consent to provide the genetic information, the authentication information entered into the customer terminal by the customer who was informed of the authentication information received by the collaborating company terminal, and the customer's identification information from the customer terminal, Upon receiving the aforementioned consent, authentication information, and identification information, the genetic information linked to the customer's identification information is displayed on the linked company's terminal for a certain period of time. A method that includes this.

5. Gene information provision device Request acquisition unit that receives requests from partner company terminals to provide customer genetic information. In response to a request to provide the aforementioned customer's genetic information, the authentication information issuing unit transmits authentication information for one-time authentication to the aforementioned partner company's terminal. A consent acquisition unit receives from the customer terminal the customer's consent to provide the genetic information, the authentication information entered into the customer terminal by the customer who was informed of the authentication information received by the collaborating company terminal, and the customer's identification information. Upon receiving the aforementioned consent, authentication information, and identification information, the Genetic Information Provision Unit displays the genetic information linked to the customer's identification information on the linked company's terminal for a limited period of time. A program designed to function as such.

Images